Wikipedia -WSS

Wikipedia

author：fashion 2025-09-27 12:58:26 - browse：1

Mel Evans/AP

Merck announced Monday it will acquire Harpoon Therapeutics and its pipeline of immune-based cancer drugs for $680 million. Merck will pay $23 per share, just over twice Harpoon’s market price entering the week.

The bolt-on deal comes as Merck’s top brass searches for ways to bolster the company’s revenue after it loses exclusivity on Keytruda, long the world’s most lucrative cancer drug. That could come as soon as 2028.

Keytruda, a PD-(L)1 inhibitor, works by turning off a “brake” on T cells, allowing roving immune cells to attack tumors. Harpoon’s pipeline belongs to a new class of cancer drugs designed to grab onto the T cells and tumor cells and bring them together.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： Personalized medicine goes far beyond genetics

explore

WSS

How I helped Pfizer think through the ethics of Viagra

The a glaring gap in research on serious mental illness and primary care

Mass General totes up its waste in a move to tackle climate change

CDC recommends RSV monoclonal antibody for infants

Tocagen's brain cancer gene therapy trial continues. Investors worry

Texas Department of Public Safety speaks out on migrant abuse allegations

leisure time

Wikipedia

knowledge

Malaria cases in Florida and Texas: Here’s what you need to know

FDA scientists endorse Pfizer/BioNTech Covid

Cancer drug shortages should be causing more outrage

Stanford president faces new allegations over 1999 paper

Trump demands the U.S. pay no more for drugs than other countries … again

EF3 tornado rips through North Carolina amid extreme weather nationwide

Hollywood unions extend contract negotiations for actors

How to ethically and practically extend health care to all

What does generative AI mean for health care? We asked experts

Heart disease in astronauts blamed on cosmic radiation

entertainment

EF3 tornado rips through North Carolina amid extreme weather nationwide

FDA scientists endorse Pfizer/BioNTech Covid

A Q&A with Gavi’s Seth Berkley on vaccines, Covid, and more

Group behind ProMed defends move to subscription

Biotech startup Celsius cuts 75% of staff ahead of first trial start

Biotech startup Celsius cuts 75% of staff ahead of first trial start

focus

explore

explore

leisure time